Matthew Butler
Wellcome Doctoral Clinical Research Fellow and Specialist Registrar in Psychiatry
Data updated
Research Footprint
Matthew Butler appears in 5 tracked papers (2020–2026), most studied alongside Placebo, Ayahuasca and Psilocybin, across Safety & Risk Management, Healthy Volunteers and Anxiety Disorders.
Most-cited paper: Ceremonial Ayahuasca in Amazonian Retreats-Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study (72 citations).
Frequent co-authors: James Rucker, Mathieu Seynaeve and Allan Young.
Background & Research
Dr Matthew Butler is a specialist registrar in psychiatry and a Wellcome Doctoral Clinical Research Fellow at King’s College London. His research interests include neuropsychiatry, psychopharmacology, and non-pharmacological treatment effects such as placebo and expectancy, and he is currently studying psilocybin in functional neurological disorder. He holds MBChB (Hons) and MRes (Dist) from the University of Manchester and is a member of the Royal College of Psychiatrists.
Key Impact
He is a King’s College London psychiatrist-researcher publishing on psychedelics, placebo/expectancy, and functional neurological disorder.
Collaboration Network
9 collaborators· click a node to visit their profile
Full network →